{
  "id": 595,
  "text": "</td><td>Conditional recommendation, low-certainty evidence </td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: </td><td>Conditional recommendation, low-certainty evidence </td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested aga\n\n<question>: ",
  "ChatGPT_response_0": "根据建议，对于接受治疗的HIV阳性妇女，应该在接受治疗后的12个月内使用HPV DNA测试进行重新测试而不是用细胞学或VIA或联合测试。这样做可以更好地检测病变情况，特别是对于有CIN2/3或腺癌原位 (AIS)治疗史的妇女。如果HPV DNA测试结果为阴性，建议在12个月后再次进行测试，如果再次为阴性，则可以过渡到推荐的常规筛查间隔。",
  "query": "对于HIV阳性妇女，是否应该在接受治疗后的12个月内使用HPV DNA测试进行重新测试，而不是用细胞学或VIA或联合测试？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于HIV阳性妇女，是否应该在接受治疗后的12个月内使用HPV DNA测试进行重新测试，而不是用细胞学或VIA或联合测试？\n\n<reference text>: </td><td>Conditional recommendation, low-certainty evidence </td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.\n\n<reply>: ",
  "response": "根据建议，对于接受治疗的HIV阳性妇女，应该在接受治疗后的12个月内使用HPV DNA测试进行重新测试而不是用细胞学或VIA或联合测试。这样做可以更好地检测病变情况，特别是对于有CIN2/3或腺癌原位 (AIS)治疗史的妇女。如果HPV DNA测试结果为阴性，建议在12个月后再次进行测试，如果再次为阴性，则可以过渡到推荐的常规筛查间隔。"
}